Stiffness
Also known as: Stiffened, Stiffness
Methodology & AI Transparency ⓘ
Stiffness Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: Stiffness (also termed Stiffened or Stiffness) is an ICD-10-CM indexed diagnosis (R29.898) within Preventive Screening & Blood Biomarkers.
- 2 Real-world patient consensus: Synonyms for Stiffness (R29.898): Stiffened, Stiffness (Preventive & Labs).
- 3 Typical cash cost range: Workup highlights for Stiffness (R29.898): evidence-based risk stratification in Stiffness (R29.898: pairing lifestyle nutrition/exercise).
- 4 Top reported side effects / signs: Objective lab/clinical target for Stiffness: ApoB, HbA1c & in Stiffness (R29.898: hs-CRP Triad) (ApoB < 80 mg/dL; HbA1c < 5.5%; hs-CRP < 1.0 mg/L (R29.898)) and CBC, CMP & in Stiffness (R29.898: eGFR Baseline).
Ask our AI Specialists anything about Stiffness
What Is Stiffness?
Stiffness (also termed Stiffened or Stiffness) is an ICD-10-CM indexed diagnosis (R29.898) within Preventive Screening & Blood Biomarkers. Clinical evaluation centers on evidence-based risk stratification in Stiffness (R29.898: pairing lifestyle nutrition/exercise) alongside serial ApoB, HbA1c & in Stiffness (R29.898: hs-CRP Triad) tracking (ApoB < 80 mg/dL; HbA1c < 5.5%; hs-CRP < 1.0 mg/L (R29.898)) to guide individualized care.
Pathophysiology, Underlying Causes & Clinical Presentation
At the cellular and tissue level in preventive & labs, Stiffness (R29.898) involves subclinical shifts in in Stiffness (R29.898: glycemic sensitivity). progression correlates with shifts in ApoB, HbA1c & in Stiffness (R29.898: hs-CRP Triad) (ApoB < 80 mg/dL; HbA1c < 5.5%; hs-CRP < 1.0 mg/L (R29.898)).
Common Symptoms & Clinical Signs
- • Presentation of Stiffness (R29.898): proactive annual or in Stiffness (R29.898: semiannual health checkup)
- • Secondary Stiffness clinical sign: follow-up of borderline in Stiffness (R29.898: laboratory values before)
- • Symptom flares in Stiffness correlating with ApoB, HbA1c & in Stiffness (R29.898: hs-CRP Triad) deviation outside ApoB < 80 mg/dL; HbA1c < 5.5%; hs-CRP < 1.0 mg/L (R29.898)
- • Functional preventive & labs impact requiring evidence-based risk stratification in Stiffness (R29.898: pairing lifestyle nutrition/exercise) evaluation (R29.898)
Primary Federal Reference: NIH / National Library of Medicine MedlinePlus Entry ↗
Stiffness Diagnostic Classification & Lab Markers
| Metric | Verified Benchmark | Source |
|---|---|---|
| ICD-10-CM Diagnostic Code | R29.898 | WHO / CMS ICD-10-CM Clinical Classification |
| Clinical Specialty Hub | Preventive Screening & Blood Biomarkers | NIH MedlinePlus Health Topics |
| Diagnostic / Lab Marker: ApoB, HbA1c & in Stiffness (R29.898: hs-CRP Triad) | ApoB < 80 mg/dL; HbA1c < 5.5%; hs-CRP < 1.0 mg/L (R29.898) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: CBC, CMP & in Stiffness (R29.898: eGFR Baseline) | Within optimal preventive reference intervals (R29.898) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: 25-Hydroxy Vitamin D, in Stiffness (R29.898: Ferritin & B12) | 25(OH)D 40–65 ng/mL; Ferritin 50–150 ng/mL (R29.898) | Clinical Reference Target Range |
FDA-Monographed Medications & Public Cash Price Reference for Stiffness
| Medication | Pharmacologic Class | Patient Worth-It | CMS NADAC / Unit | Typical Lowest Cash |
|---|---|---|---|---|
| Captopril and Hydrochlorothiazide Captopril and Hydrochlorothiazide Generic • RxCUI RXN-16571829-2625 | Thiazide Diuretic | 81% | $0.2998 | $ 20.64 /mo |
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Stiffness)
| Study & Plain-English Finding | Sample (N) | Rigor | Primary Source |
|---|---|---|---|
| New Insights on Effect of Oral Phosphodiesterase-5 Inhibitors on Sperm: What a 1,317-Participant Study Found Oral PDE5 inhibitors treatment could modestly increase the sperm motility and morphology in infertile men. Urology • 2017-07-15 • Meta-Analysis | N = 1,317 | 94/100 | PMID 28259808 ↗ |
| New Insights on A Protective Role for Arachidonic Acid Metabolites against Advanced Colorectal: What a 256-Participant Study Found Selenium supplementation was associated with a significantly smaller increase in 5-HETE after 12 months compared to the placebo, though no other results were statistically significant. Nutrients • 2021-10-29 • Phase III Randomized Trial | N = 256 | 93/100 | PMID 34836131 ↗ |
| New Insights on Differences and similarities in clinical and functional responses among patients: What a 1,146-Participant Study Found These results suggest that patients with a greater response did well, irrespective of which therapy they received. Arthritis research & therapy • 2021-08-24 • Phase III Randomized Trial | N = 1,146 | 90/100 | PMID 34429160 ↗ |
| Can This Approach Help? Inside the Latest Research on Quantifying the relationship between disability progression and quality of life These results, generated from high-quality clinical trial data, demonstrated a strong and consistent relationship between disability and QoL in patients with NMOSD. Multiple sclerosis and related disorders • 2022-01-15 • Phase III Randomized Trial | Multi-cohort | 88/100 | PMID 35158426 ↗ |
| Can This Approach Help? Inside the Latest Research on Time to improvement of pain, morning stiffness, fatigue, and disease activity in Improvements in AS core domains occurred more rapidly with tofacitinib vs. Arthritis research & therapy • 2024-05-24 • Phase III Randomized Trial | N = 133 | 88/100 | PMID 38790040 ↗ |
Stiffness Patient Community & “People Like Me” Threads
Filter Stiffness community threads and patient logs by age, biological sex, dosage, and treatment duration.